Bank of New York Mellon Corp - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$985,824
-12.4%
95,065
+21.0%
0.00%
Q2 2023$1,125,366
+103.8%
78,587
+1.6%
0.00%
Q1 2023$552,187
-38.4%
77,337
-3.3%
0.00%
Q4 2022$896,870
+10.2%
79,935
+8.7%
0.00%
Q3 2022$814,000
+49.6%
73,520
+14.2%
0.00%
Q2 2022$544,000
-34.8%
64,357
+5.0%
0.00%
Q1 2022$834,000
-28.6%
61,288
+3.3%
0.00%
Q4 2021$1,168,000
-37.4%
59,340
+2.1%
0.00%
Q3 2021$1,867,000
+8.5%
58,142
+14.4%
0.00%
Q2 2021$1,720,000
+11.1%
50,819
+23.3%
0.00%
Q1 2021$1,548,000
+6.7%
41,222
-5.6%
0.00%
Q4 2020$1,451,000
-9.9%
43,668
-0.6%
0.00%
Q3 2020$1,610,000
+10.9%
43,932
-0.4%
0.00%
Q2 2020$1,452,000
+47.1%
44,115
+15.4%
0.00%
Q1 2020$987,000
+27.8%
38,233
+54.2%
0.00%
Q4 2019$772,00024,7940.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,760,869$39,000,21212.45%
Frazier Life Sciences Management, L.P. 10,109,279$104,833,2236.96%
Decheng Capital Management III (Cayman), LLC 850,000$8,814,5002.94%
Carlyle Group Inc. 3,496,808$36,191,9631.57%
Ghost Tree Capital, LLC 395,000$4,096,1501.35%
Newtyn Management, LLC 500,000$5,185,0001.28%
Altium Capital Management LP 220,000$2,281,4001.19%
StepStone Group LP 422,085$4,377,0210.98%
MPM BioImpact LLC 347,332$3,601,8330.96%
NEA Management Company, LLC 1,276,595$12,238,2900.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders